Jonathan Langer | Source | CEO at Medigate

Partech is a very sophisticated technology investor. With their backing, we will be able to quickly expand to help healthcare organizations around the world experience the same ROI as those in the United States. We are very appreciative of the continued support we receive from our investors at YL Ventures, USVP and Blumberg Capital and are excited to add Partech and Maor Investments to our team as we enter in the next phase of our growth.

As healthcare organizations adopt new digital innovations and new advances – such as telehealth – they must also embrace the security protocols and framework to protect this technology and guard against clinical risks. Our partnership with Rapid7 is critical for our healthcare customers who are increasingly under attack. It’s essential they have the tools to protect themselves and take action as warranted. By combining the power of Rapid7’s robust cybersecurity with Medigate’s clinical knowledge and insights, we’re not only allowing for better device management, but taking proactive steps to achieve true security at all levels of the hospital.

Data is the lifeblood of every healthcare organization, yet much of this data is being shared over a growing network of IoT and medical devices – where each device could be used as a network access point for cyber criminals. Protecting this patient data and achieving superior network security is essential for every healthcare organization as we have seen an increase in the number of attacks in the past several months. Our partnership with Splunk is simplifying the process to locate devices, analyze their use and alert IT to solve any potential threats so healthcare institutions can automatically protect this sensitive information.